AWP
GILD icon

Ascent Wealth Partners’s Gilead Sciences GILD Stock Holding History

Ascent Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.42M Buy
58,756
+1,412
+2% +$186K 0.74% 40
2026
Q1 		$7.99M Buy
+57,344
New +$8.03M 0.93% 34
2018
Q1 		– Sell
-8,121
Closed -$582K – 123
2017
Q4 		$582K Buy
8,121
+20
+0.2% +$1.52K 0.22% 82
2017
Q3 		$656K Hold
8,101
– – 0.26% 74
2017
Q2 		$573K Buy
8,101
+148
+2% +$9.85K 0.25% 75
2017
Q1 		$540K Sell
7,953
-541
-6% -$38K 0.24% 76
2016
Q4 		$608K Buy
8,494
+1,634
+24% +$121K 0.3% 70
2016
Q3 		$543K Sell
6,860
-9
-0.1% -$731 0.27% 71
2016
Q2 		$573K Sell
6,869
-105
-2% -$9.32K 0.3% 69
2016
Q1 		$641K Buy
6,974
+160
+2% +$14.4K 0.34% 67
2015
Q4 		$690K Buy
6,814
+115
+2% +$12K 0.39% 64
2015
Q3 		$658K Buy
6,699
+175
+3% +$19.4K 0.39% 62
2015
Q2 		$763K Buy
6,524
+570
+10% +$62.3K 0.42% 56
2015
Q1 		$585K Buy
+5,954
New +$605K 0.32% 67
2014
Q3 		– Sell
-2,484
Closed -$206K – 106
2014
Q2 		$206K Buy
+2,484
New +$193K 0.13% 104

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ascent Wealth Partners's GILD Position: Q2 2026 in Review

Ascent Wealth Partners increased its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, buying an estimated $186K and bringing the position to 58,756 shares worth $7.42M. The position accounts for 0.74% of the portfolio, ranked #40.

Ascent Wealth Partners first reported a position in GILD in Q2 2014 and has held it in 15 quarters since. The position peaked at $7.99M in Q1 2026. 2,281 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ascent Wealth Partners held 58,756 shares of Gilead Sciences worth $7.42M as of Q2 2026.
  • Ascent Wealth Partners bought 1,412 Gilead Sciences shares in Q2 2026, an estimated $186K.
  • Gilead Sciences made up 0.74% of Ascent Wealth Partners's portfolio in Q2 2026, its #40 holding.
  • Ascent Wealth Partners first reported a position in Gilead Sciences in Q2 2014 and has held it in 15 quarters since.
  • Ascent Wealth Partners's Gilead Sciences position peaked at $7.99M in Q1 2026.
  • 2,281 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ascent Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.